Why VIVS? VivoSim Labs, Inc. Analysis, Price & AI Insights | Whystock
VIVS
$1.39-0.02 (-1.42%)
Market ClosedLast close May 8
VivoSim Labs, Inc., a pharmaceutical and biotechnology services company, provides testing of drugs and drug candidates in three-dimensional (3D) human tissue models of liver and intestine.